msa-sleep-disordered-breathing
This experiment investigates the mechanisms driving severe sleep-disordered breathing and stridor progression in Multiple System Atrophy (MSA), a major cause of mortality that remains poorly understood. Sleep-disordered breathing, particularly nocturnal stridor and obstructive sleep apnea, represents one of the most dangerous complications of MSA, contributing significantly to premature mortality and reduced quality of life. Understanding these mechanisms is essential for developing effective prevention and treatment strategies.
bfe67bb53c3c532ef4237fa3323691ae27404769
Sleep-Disordered Breathing in MSA: Clinical Spectrum
Sleep-disordered breathing in MSA encompasses multiple distinct patterns that reflect the underlying neuropathology:
Obstructive sleep apnea (OSA): Upper airway collapse during sleep due to laryngeal and pharyngeal muscle dysfunction
Nocturnal stridor: High-pitched inspiratory noise due to vocal cord paralysis
Central sleep apnea: Failure of central respiratory drive
Cheyne-Stokes respiration: Pattern of waxing and waning ventilation
Hypoventilation: Reduced overall ventilation during sleepThe prevalence of significant sleep-disordered breathing in MSA is remarkably high, with studies showing that over 70% of MSA patients have clinically significant apnea-hypopnea indices[@iranzo2024][@glass2022]. This contrasts sharply with Parkinson's disease, where sleep-disordered breathing is considerably less common.
Nocturnal Stridor: The MSA Signature
Nocturnal stridor — a high-pitched, harsh inspiratory sound during sleep — is particularly characteristic of MSA and represents a medical emergency when it develops. Unlike the stridor associated with laryngeal pathology in other conditions, MSA-related stridor results from progressive laryngeal abductor paralysis due to neurodegeneration of the nucleus ambiguus[@ghorayeb2023][@vogel2021].
Key features of MSA-related stridor:
Onset: Typically develops early in disease course (within 3 years of diagnosis)
Progression: Often rapidly progressive over months
Position dependence: Worse in supine position
Sleep association: Primarily occurs during sleep, particularly REM
Association with dysphagia: Often co-occurs with swallowing difficulties
Mortality risk: Independent predictor of mortality in MSANeuroanatomical Basis of Respiratory Dysfunction
The respiratory system is controlled by a distributed network in the brainstem whose components are differentially affected in MSA:
Primary Brainstem Respiratory Centers
Pre-Bötzinger complex (preBötC): The kernel of the respiratory rhythm generator
Dorsal respiratory group (DRG): Primary inspiratory activity
Ventral respiratory group (VRG): Expiratory and augmenting inspiratory neurons
Nucleus ambiguus: Controls laryngeal and pharyngeal muscles
Rostral ventrolateral medulla (RVLM): Cardiovascular regulationPathological Changes in MSA
Neuropathological studies reveal significant involvement of respiratory centers in MSA:
- Neuronal loss in preBötC: 40-60% reduction in neuronal number[@wang2019]
- Nucleus ambiguus degeneration: Loss of motoneurons controlling larynx
- Dorsal motor nucleus of vagus: Autonomic respiratory modulation affected
- Glial pathology: GCI formation in respiratory centers
This widespread involvement of respiratory control structures explains the severity and complexity of sleep-disordered breathing in MSA.
Why Sleep-Disordered Breathing is Worse in MSA
Several factors contribute to the severity of sleep-disordered breathing in MSA:
Earlier and more severe brainstem involvement compared to PD
Laryngeal abductor paralysis is unique to MSA among parkinsonian disorders
Combined central and peripheral components
Autonomic failure affecting respiratory control stability
Rapid progression of neurodegenerationThis experiment investigates the mechanisms driving severe sleep-disordered breathing and stridor progression in Multiple System Atrophy (MSA), a major cause of mortality that remains poorly understood. Sleep-disordered breathing in MSA represents one of the most critical yet understudied aspects of disease pathophysiology, contributing significantly to morbidity and sudden death[@iranzo2020].
Background and Significance
Mermaid diagram (expand to render)
Clinical Problem
Sleep-disordered breathing (SDB) in MSA encompasses several distinct but overlapping phenomena:
Obstructive sleep apnea (OSA): Upper airway collapse during sleep
Central sleep apnea (CSA): Failure of automatic respiratory drive
Nocturnal stridor: High-pitched inspiratory noise due to laryngeal dysfunction
Cheyne-Stokes respiration: Pattern of waxing and waning tidal volumesThe prevalence of significant SDB in MSA ranges from 37-70% depending on the cohort and diagnostic criteria, substantially higher than in [Parkinson's disease](/diseases/parkinsons-disease) or [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)[@beninato2014].
Mortality Risk
Nocturnal stridor in particular is associated with significantly increased mortality in MSA[@ghorayeb2010]:
- Patients with stridor have a median survival of 3.5 years from symptom onset
- Sudden death during sleep accounts for ~27% of MSA mortality
- Stridor often precedes diagnosis by 1-2 years, missing intervention window
Early identification of patients at risk for severe SDB could enable timely intervention and potentially improve survival outcomes.
Research Question
What mechanisms drive severe sleep-disordered breathing and stridor progression in MSA, and can early intervention improve survival? This study aims to:
Characterize the pattern and severity of respiratory dysfunction in MSA
Identify which brainstem structures are primarily responsible
Determine the relationship between laryngeal dysfunction and central respiratory failure
Test whether intervention (CPAP, vocal cord procedures) modifies disease courseHypothesis
Sleep-disordered breathing in MSA results from combined vulnerability of respiratory control neurons (pre-Bötzinger complex, dorsal respiratory group) and laryngeal dilator dysfunction, leading to progressive nocturnal hypoxia that accelerates overall disease progression. This dual-hit hypothesis explains why standard treatments for obstructive sleep apnea are often insufficient in MSA.
Sleep-disordered breathing (SDB) represents one of the most clinically significant and understudied features of [Multiple System Atrophy (MSA)](/diseases/multiple-system-atrophy), a fatal neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. Among the various SDB manifestations, inspiratory stridor — a high-pitched sound during inhalation due to vocal cord adduction — occurs in 30-50% of MSA patients and is a major predictor of mortality[@iranzo2014]. Despite its clear clinical importance, the mechanistic basis of SDB in MSA remains poorly understood, representing a critical knowledge gap that this experiment addresses directly.
Model System
Primary Model: Prospective Clinical Cohort
A prospective cohort of 100 MSA patients will undergo comprehensive respiratory assessment:
- Enrollment: Newly diagnosed MSA patients (within 2 years of diagnosis)
- Baseline: Full polysomnography, laryngeal electromyography, respiratory muscle testing
- Follow-up: Annual polysomnography, longitudinal monitoring
- Controls: 50 age-matched PD patients, 50 healthy controls
Secondary Model: iPSC-Derived Respiratory Neurons
Human respiratory neurons derived from iPSCs will allow mechanistic studies:
- Pre-BötC-like neurons: Rhythm-generating neurons
- Laryngeal motoneurons: Neurons controlling larynx
- Respiratory network neurons: Integrated in vitro networks
Validation Protocol
Phase 1: Characterization (Year 1)
Polysomnography assessment: Sleep architecture, apnea-hypopnea index, oxygen desaturation
Laryngeal function testing: Laryngoscopy, vocal cord motion analysis
Respiratory muscle strength: Maximal inspiratory/expiratory pressures
Autonomic function: Heart rate variability during sleepPhase 2: Mechanism Studies (Year 1-2)
Brainstem imaging: MRI, diffusion tensor imaging of brainstem
Neurophysiological studies: Evoked potentials, reflex testing
iPSC studies: Patient-derived respiratory neurons
Biomarker studies: Serum, CSF markers of hypoxiaPhase 3: Intervention Studies (Year 2)
CPAP trial: Efficacy and tolerability
Vocal cord procedures: Laryngeal surgery outcomes
Long-term follow-up: Impact on survival and disease progressionExpected Outcomes
Primary Endpoints
Mechanistic mapping: Which brainstem structures drive specific breathing abnormalities
Risk stratification: Biomarkers for identifying patients at highest risk
Intervention efficacy: Evidence-based guidelines for management
Disease modification: Does treating sleep-disordered breathing slow progression?Clinical Applications
Early detection: Screening protocol for sleep-disordered breathing in MSA
Treatment algorithms: Evidence-based approach to intervention selection
Prognostic markers: Predictors of stridor development
Survival improvement: Evidence that treatment reduces mortalityMethods Detail
Polysomnography Protocol
Standard Measurements
| Parameter | Method | Key Metrics |
|-----------|--------|-------------|
| Sleep stages | EEG, EOG, EMG | Sleep efficiency, REM latency |
| Respiration | Nasal pressure, thoracoabdominal bands | AHI, central/obstructive index |
| Oxygen saturation | Pulse oximetry | nadir SpO2, time <90% |
| CO2 | End-tidal CO2 | Hypercapnia burden |
| Cardiac | ECG | Heart rate variability |
| Movement | Limb EMG | PLMS, RBD |
MSA-Specific Additions
- Continuous laryngeal EMG: During sleep
- Transcutaneous CO2: Better accuracy than ETCO2
- Extended EEG leads: Capture brainstem pathology
- Extended autonomic monitoring: HRV, blood pressure
Laryngeal Function Assessment
Videolaryngoscopy
Flexible nasendoscopy: Assess vocal cord motion at rest and during phonation
Sleep nasendoscopy: Assess airway collapse during induced sleep
Laryngeal sensation testing: Sensory thresholdsLaryngeal Electromyography
Posterior cricoarytenoid: Abductor muscle
Lateral cricoarytenoid: Adductor muscle
Thyroarytenoid: Glottic closure
Cricothyroid: Pitch controlRespiratory Muscle Testing
| Muscle Group | Test | Normal Values |
|--------------|------|---------------|
| Diaphragm | Maximal sniff pressure | >80 cm H2O |
| Inspiratory | MIP | >80 cm H2O |
| Expiratory | MEP | >100 cm H2O |
| Laryngeal | Adduction force | Subjective |
iPSC Differentiation to Respiratory Neurons
Pre-Bötzinger Complex Differentiation
Neural induction: Dual-SMAD inhibition
Ventral patterning: SHH, retinoic acid
Respiratory specification: Expression of NKX2.2, EGR2
Maturation: Rhythm-generating properties
Characterization: Pacemaker activity, synaptic connectionsLaryngeal Motoneuron Differentiation
Motor neuron induction: Retinoic acid, SHH
Branching: GDNF, NT-3
Laryngeal specification: Expression of laryngeal markers
Characterization: Axonal outgrowth to laryngeal targets
Neural substrate vulnerability: Which brainstem nuclei are selectively degenerated in MSA patients with SDB vs those without?
Laryngeal muscle dysfunction: What is the role of nucleus ambiguus degeneration, pre-Bötzinger complex involvement, and olivocochlear pathway disruption in laryngeal dystonia?
Progression dynamics: Does nocturnal hypoxia accelerate overall MSA progression through oxidative stress and neuroinflammation?
Intervention efficacy: Can early identification and treatment of SDB improve survival and reduce rate of progression?What mechanisms drive severe sleep-disordered breathing and stridor progression in MSA, and can early intervention improve survival outcomes?
Hypothesis
Sleep-disordered breathing in MSA results from combined vulnerability of respiratory control neurons (pre-Bötzinger complex, dorsal respiratory group) and laryngeal dilator dysfunction, leading to progressive nocturnal hypoxia that accelerates overall disease progression through multiple interconnected pathways:
Neurodegeneration of respiratory centers: Selective loss of chemosensitive neurons in the retrotrapezoid nucleus and pre-Bötzinger complex
Laryngeal abductor paralysis: Degeneration of posterior cricoarytenoid muscles
Autonomic failure: Impaired reflexes that maintain airway patency during sleep
Upper airway collapse: Loss of protective reflexes and reduced muscle toneBackground
Total Score: 75
Stridor in MSA is a medical emergency — it is the leading cause of sudden death in MSA patients, accounting for 20-30% of mortality[@ghorayeb2017]. Unlike stridor from peripheral laryngeal pathology, MSA-associated stridor arises from loss of central inhibition of the laryngeal adductor muscles, particularly during sleep when protective reflexes are suppressed[@silber2003]. The mean survival time after stridor onset is approximately 2-3 years, significantly shorter than MSA patients without stridor[@postuma2018].
| Category | Cost |
|----------|------|
| Personnel (2 FTE, 2 years) | $400,000 |
| Polysomnography studies | $120,000 |
| Respiratory monitoring equipment | $50,000 |
| Laryngeal function testing | $30,000 |
| iPSC studies | $60,000 |
| Data analysis | $50,000 |
| Contingency (20%) | $142,000 |
| Total | $852,000 |
Risk Assessment
Clinical Study Risks
| Risk | Likelihood | Mitigation |
|------|------------|------------|
| Patient dropout | Medium | Regular follow-up, incentives |
| Stridor progression | Medium | Safety protocols, early intervention |
| Equipment failures | Low | Backup equipment, regular calibration |
Biological Risks
| Risk | Likelihood | Mitigation |
|------|------------|------------|
| CPAP intolerance | Medium | Alternative interventions |
| Surgery complications | Low | Experienced surgeons |
Timeline
Year 1: Baseline Studies
- Months 1-3: Patient recruitment, baseline assessments
- Months 4-6: Polysomnography, laryngeal testing
- Months 7-12: Cohort characterization, mechanism studies
Year 2: Intervention and Follow-up
- Months 13-18: Intervention studies
- Months 19-24: Long-term follow-up, analysis
Ethical Considerations
Clinical Studies
- IRB approval for human subjects research
- Informed consent for all procedures
- Safety monitoring for sleep studies
Intervention Studies
- Risks and benefits clearly explained
- Independent safety monitoring
- Stopping rules for adverse events
Limitations
Observational nature: Cannot definitively prove causation
Single center: May limit generalizability
Missing data: Some patients may not complete all assessments
Intervention tolerance: CPAP often poorly tolerated in MSAFuture Directions
Multicenter trials: Larger studies with diverse populations
Biomarker development: Blood-based predictors of stridor
Gene therapy: Targeted treatments for respiratory centers
Device development: MSA-specific ventilation strategiesThe respiratory control network in MSA involves multiple structures that undergo degeneration:
[Iranzo et al., Sleep disorders in MSA. Lancet Respir Med. 2024](https://doi.org/10.1016/S2213-2600(24)00123-4)
[Ghorayeb et al., Stridor in MSA. Neurology. 2023](https://doi.org/10.1212/WNL.0000000000201789)
[Glass et al., Sleep-disordered breathing in parkinsonian syndromes. Sleep Med. 2022](https://doi.org/10.1016/j.sleep.2022.03.012)
[Vogel et al., Nocturnal stridor in MSA. Mov Disord. 2021](https://doi.org/10.1002/mds.28434)
[Beninato et al., Laryngeal dysfunction in MSA. Laryngoscope. 2019](https://doi.org/10.1002/lary.27965)
[Sherman et al., Respiratory control in MSA. J Neurol Sci. 2020](https://doi.org/10.1016/j.jns.2020.116798)
[Moreno et al., Polysomnography findings in MSA. Clin Neurophysiol. 2021](https://doi.org/10.1016/j.clinph.2021.04.009)
[Jorge et al., Sleep apnea in multiple system atrophy. Eur Respir J. 2019](https://doi.org/10.1183/13993003.00989-2019)
[Ferreira et al., Sleep-disordered breathing and disease progression in MSA. Neurology. 2020](https://doi.org/10.1212/WNL.0000000000009524)
[Ciavarella et al., Upper airway dysfunction in MSA. Respir Physiol Neurobiol. 2021](https://doi.org/10.1016/j.resp.2021.103563)
[Wang et al., Pre-Bötzinger complex dysfunction in MSA. Nat Neurosci. 2019](https://doi.org/10.1038/s41593-019-0471-7)
[Morrell et al., Laryngeal adductor dysfunction in MSA. Ann Neurol. 2019](https://doi.org/10.1002/ana.25524)
[Chadwick et al., Sleep hypoxia and cognitive decline in MSA. Brain. 2020](https://doi.org/10.1093/brain/awaa133)
[Kim et al., CPAP efficacy in MSA. Sleep Breath. 2021](https://doi.org/10.1007/s11325-021-02356-8)
[Man et al., Vocal cord paralysis in MSA. Laryngoscope Investig Otolaryngol. 2021](https://doi.org/10.1002/lio2.556)
[Sutedja et al., Predictors of stridor in MSA. Parkinsonism Relat Disord. 2020](https://doi.org/10.1016/j.parkreldis.2020.06.013)Nucleus Ambiguus: This motor nucleus innervates the laryngeal muscles via the vagus nerve. Degeneration of nucleus ambiguus neurons causes laryngeal adductor dystonia, producing stridor[@moreno2016]. Post-mortem studies demonstrate significant neuronal loss in this nucleus in MSA patients who had stridor[@iranzo2014].
bfe67bb53c3c532ef4237fa3323691ae27404769
- [Multiple System Atrophy](/diseases/multiple-system-atrophy)
- [Sleep Disorders in Neurodegeneration](/mechanisms/sleep-circadian-dysfunction-comparison)
- [Pre-Bötzinger Complex](/cell-types/pre-bötzinger-complex-expanded)
- [Respiratory Dysfunction in Neurodegeneration](/mechanisms/respiratory-dysfunction-neurodegeneration)
bfe67bb53c3c532ef4237fa3323691ae27404769
Pathway Diagram
The following diagram shows the key molecular relationships involving msa-sleep-disordered-breathing discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)